Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Trump Agencies Move to Bolster Health-Care Price Transparency
Posted
December 22, 2025
Views
444
Likes
2
Engagement
0.45%
December 22, 2025
444
2
0.45%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
4:45Now PlayingJ.D. Hayworth, Pharmaceutical Reform Alliance spokesman and former Republican Congressman from Arizona, discusses the recent push for lower drug and health-care prices in the US.
The Trump administration proposed new medical price transparency rules Friday in a bid to strengthen rules released during the president’s first term.
The proposed rule (RIN: 0938-AV64) would make changes to payer price transparency regulations in an effort to improve the accessibility of pricing disclosures to consumers. It aims to update the standardization and reliability of the public pricing disclosures from non-legacy group health plans and health insurance issuers offering non-legacy group and individual health insurance coverage.
“Americans have a right to know what health care costs before they pay for it,” Health and Human Services Secretary Robert F. Kennedy Jr. said in a statement. “This proposal delivers real transparency by turning hidden pricing into clear, usable information—so families can make informed decisions and hold the system accountable.”
The proposal from the Centers for Medicare & Medicaid Services and departments of Labor and Treasury would simplify how data is organized, eliminate information deemed unnecessary, and make consumer-facing cost tools more accessible to the public, according to the statement.
The rule also targets contracted rates for services outside a doctor’s specialty, after critics said “ghost rates” clog up the files.
A February executive order from President Donald Trump directed the Health and Human Services, Labor, and Treasury departments to issue rules requiring precise figures, as well as new guidance to standardize disclosures.
Trump finalized price transparency rules for both health plans and medical providers during his first term. But a separate measure to disclose what plans pay for prescription drugs was never implemented, following an industry lawsuit and concerns of duplicative reporting requirements.
The administration also plans to propose a rule injecting more transparency into revenue received by pharmacy benefit managers, which oversee the prescription drug benefit for health plans. The rule follows a separate executive order aimed at fees that PBMs pay to brokers for employer client referrals.
--------
Watch Bloomberg Radio LIVE on YouTube
Weekdays 7am-6pm ET
Follow us on X
Subscribe to our Podcasts:
Bloomberg Daybreak
Bloomberg Surveillance
Bloomberg Intelligence
Balance of Power
Bloomberg Businessweek
Listen on Apple CarPlay and Android Auto with the Bloomberg Business app:
Apple CarPlay
Android Auto
Visit our YouTube channels:
Bloomberg Podcasts
Bloomberg Television
Bloomberg Originals
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
